The tumor microenvironment in colorectal carcinogenesis

Cancer Microenvironment

Volumn 3, Issue 1, 2010, Pages 149-166

  Peddareddigari, Vijay G ^a   Wang, Dingzhi ^a   Dubois, Raymond N ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Colon cancer; Extracellular matrix; Stroma; Tumor infiltrating cells; Tumor microenvironment

Indexed keywords

ANGIOPOIETIN RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; CATHEPSIN; COLLAGEN; CYCLOOXYGENASE 2; CYSTEINE; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; GELATINASE A; GELATINASE B; HYALURONIC ACID; INDOLEAMINE 2,3 DIOXYGENASE; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LAMININ; METALLOPROTEINASE; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROSTAGLANDIN; PROSTAGLANDIN E2; PROTEOGLYCAN; SCATTER FACTOR; SERINE PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; BONE MARROW CELL; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL INTERACTION; CELLULAR IMMUNITY; COLORECTAL CANCER; CONFERENCE PAPER; DENDRITIC CELL; DRUG RESEARCH; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXPERIMENTAL MODEL; FIBROBLAST; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; LYMPHOCYTE; MAST CELL; MESENCHYMAL STEM CELL; METASTASIS POTENTIAL; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 78649639011     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-010-0038-3     Document Type: Conference Paper

References (291)

1. EP Whitlock JS Lin E Liles, et al. 2008 Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force Ann Intern Med 149 9 638 658 18838718
2. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 10647931 1:CAS:528:DC%2BD3cXks1CktA%3D%3D
3. A Mantovani P Allavena A Sica, et al. 2008 Cancer-related inflammation Nature 454 7203 436 444 18650914 1:CAS:528:DC%2BD1cXovV2mtbg%3D
4. F Colotta P Allavena A Sica, et al. 2009 Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 7 1073 1081 19468060 1:CAS:528:DC%2BD1MXot1CisL8%3D
5. RN DuBois FM Giardiello WE Smalley 1996 Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention Gastroenterol Clin North Am 25 4 773 791 8960892 1:STN:280:DyaK2s7itVahsw%3D%3D
6. D Wang RN DuBois 2008 Pro-inflammatory prostaglandins and progression of colorectal cancer Cancer Lett 267 2 197 203 18406516 1:CAS:528: DC%2BD1cXovF2hsLg%3D
7. WE Smalley RN DuBois 1998 Colorectal cancer and nonsteroidal anti-inflammatory drugs Adv Pharmacol 39 1 20
8. RA Gupta RN Dubois 2001 Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 Nat Rev Cancer 1 1 11 21 11900248 1:STN:280:DC%2BD387mvVOhsA%3D%3D
9. CE Eberhart RJ Coffey A Radhika, et al. 1994 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 4 1183 1188 7926468 1:STN:280: DyaK2M%2FhtFamsA%3D%3D
10. D Wang RN Dubois 2006 Prostaglandins and cancer Gut 55 1 115 122 16118353 1:CAS:528:DC%2BD28Xnt1yquw%3D%3D
11. A Greenhough HJ Smartt AE Moore, et al. 2009 The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 3 377 386 19136477 1:CAS:528:DC%2BD1MXivFSiuro%3D
12. RN DuBois A Radhika BS Reddy, et al. 1996 Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors Gastroenterology 110 4 1259 1262 8613017 1:CAS:528:DyaK28Xis1Omsb8%3D
13. MG Backlund JR Mann RN Dubois 2005 Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2 Oncology 69 Suppl 1 28 32 16210874 1:CAS:528:DC%2BD2MXhtVymt73I
14. B Rigas IS Goldman L Levine 1993 Altered eicosanoid levels in human colon cancer J Lab Clin Med 122 5 518 523 8228569 1:STN:280:DyaK2c%2FksFWkug%3D%3D
15. MG Backlund JR Mann VR Holla, et al. 2005 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer J Biol Chem 280 5 3217 3223 15542609 1:CAS:528:DC%2BD2MXovVCrug%3D%3D
16. MG Backlund JR Mann D Wang, et al. 2006 Ras up-regulation of cyclooxygenase-2 Methods Enzymol 407 401 410 16757341 1:CAS:528: DC%2BD2sXmt1Sgu70%3D
17. CS Williams M Mann RN DuBois 1999 The role of cyclooxygenases in inflammation, cancer, and development Oncogene 18 55 7908 7916 10630643 1:CAS:528:DC%2BD3cXks1KlsA%3D%3D
18. M Tsujii S Kawano S Tsuji, et al. 1998 Cyclooxygenase regulates angiogenesis induced by colon cancer cells Cell 93 5 705 716 9630216 1:CAS:528:DyaK1cXjsl2ksbw%3D
19. S Gout J Huot 2008 Role of cancer microenvironment in metastasis: focus on colon cancer Cancer Microenviron 1 1 69 83 19308686
20. C Murdoch M Muthana SB Coffelt, et al. 2008 The role of myeloid cells in the promotion of tumour angiogenesis Nat Rev Cancer 8 8 618 631 18633355 1:CAS:528:DC%2BD1cXovV2lsrY%3D
21. CE Green T Liu V Montel, et al. 2009 Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization PLoS One 4 8 e6713 19696929
22. T Tokunaga Y Oshika Y Abe, et al. 1998 Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer Br J Cancer 77 6 998 1002 9528847 1:STN:280:DyaK1c7oslKqtA%3D%3D
23. Jedinak A, Dudhgaonkar S, Sliva D (2009) Activated macrophages induce metastatic behavior of colon cancer cells. Immunobiology. PMID: 19457576
24. K Zins D Abraham M Sioud, et al. 2007 Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway Cancer Res 67 3 1038 1045 17283136 1:CAS:528:DC%2BD2sXht1yns7o%3D
25. D Wang H Wang J Brown, et al. 2006 CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer J Exp Med 203 4 941 951 16567391 1:CAS:528:DC%2BD28Xjsl2is7g%3D
26. F Okada T Kawaguchi H Habelhah, et al. 2000 Conversion of human colonic adenoma cells to adenocarcinoma cells through inflammation in nude mice Lab Invest 80 11 1617 1628 11092522 1:CAS:528:DC%2BD3cXos12gtbs%3D
27. KE de Visser A Eichten LM Coussens 2006 Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 1 24 37 16397525
28. K Ishiguro T Yoshida H Yagishita, et al. 2006 Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas Gut 55 5 695 702 16354798 1:CAS:528:DC%2BD28Xksl2hurc%3D
29. CE Lewis JW Pollard 2006 Distinct role of macrophages in different tumor microenvironments Cancer Res 66 2 605 612 16423985 1:CAS:528: DC%2BD28XlsFOmtw%3D%3D
30. A Sica P Allavena A Mantovani 2008 Cancer related inflammation: the macrophage connection Cancer Lett 267 2 204 215 18448242 1:CAS:528: DC%2BD1cXovF2hsLk%3D
31. A Sica V Bronte 2007 Altered macrophage differentiation and immune dysfunction in tumor development J Clin Invest 117 5 1155 1166 17476345 1:CAS:528:DC%2BD2sXlt1Omtrs%3D
32. I Fricke DI Gabrilovich 2006 Dendritic cells and tumor microenvironment: a dangerous liaison Immunol Invest 35 3-4 459 483 16916762 1:CAS:528: DC%2BD28XpvVCks7g%3D
33. A Sica T Schioppa A Mantovani, et al. 2006 Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy Eur J Cancer 42 6 717 727 16520032 1:CAS:528:DC%2BD28Xjs1Grt78%3D
34. A Mantovani A Sica M Locati 2007 New vistas on macrophage differentiation and activation Eur J Immunol 37 1 14 16 17183610 1:CAS:528:DC%2BD2sXhtFGitrk%3D
35. A Mantovani A Sica S Sozzani, et al. 2004 The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 25 12 677 686 15530839 1:CAS:528:DC%2BD2cXptl2ktbs%3D
36. JA Van Ginderachter K Movahedi J Van den Bossche, et al. 2008 Macrophages, PPARs, and Cancer PPAR Res 2008 169414 18615187
37. S Gordon 2003 Alternative activation of macrophages Nat Rev Immunol 3 1 23 35 12511873 1:CAS:528:DC%2BD3sXovVw%3D
38. W Xu N Schlagwein A Roos, et al. 2007 Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages Eur J Immunol 37 6 1594 1599 17474153 1:CAS:528:DC%2BD2sXntVSgs7Y%3D
39. JA Hamilton 2008 Colony-stimulating factors in inflammation and autoimmunity Nat Rev Immunol 8 7 533 544 18551128 1:CAS:528:DC%2BD1cXns1ehs7k%3D
40. FO Martinez S Gordon M Locati, et al. 2006 Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression J Immunol 177 10 7303 7311 17082649 1:CAS:528:DC%2BD28XhtFGrtrbM
41. SK Biswas L Gangi S Paul, et al. 2006 A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation) Blood 107 5 2112 2122 16269622 1:CAS:528:DC%2BD28XitFChtLc%3D
42. M Kristiansen JH Graversen C Jacobsen, et al. 2001 Identification of the haemoglobin scavenger receptor Nature 409 6817 198 201 11196644 1:CAS:528:DC%2BD3MXlvFSksA%3D%3D
43. M Stein S Keshav N Harris, et al. 1992 Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation J Exp Med 176 1 287 292 1613462 1:CAS:528: DyaK38Xks1yhsb4%3D
44. T Hagemann J Wilson F Burke, et al. 2006 Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype J Immunol 176 8 5023 5032 16585599 1:CAS:528:DC%2BD28XjtV2gt7k%3D
45. W Xu A Roos N Schlagwein, et al. 2006 IL-10-producing macrophages preferentially clear early apoptotic cells Blood 107 12 4930 4937 16497970 1:CAS:528:DC%2BD28XlvFCgtLo%3D
46. ND Savage T de Boer KV Walburg, et al. 2008 Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1 J Immunol 181 3 2220 2226 18641362 1:CAS:528: DC%2BD1cXos12ntrc%3D
47. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 6917 860 867 12490959 1:CAS:528:DC%2BD38XpsFygtb4%3D
48. S Paik S Shak G Tang, et al. 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 27 2817 2826 15591335 1:CAS:528:DC%2BD2MXhslymsw%3D%3D
49. D Bacman S Merkel R Croner, et al. 2007 TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study BMC Cancer 7 156 17692120
50. RD Leek CE Lewis R Whitehouse 1996 Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma Cancer Res 56 20 4625 4629 8840975 1:CAS:528:DyaK28XmsV2isbk%3D
51. I Takanami K Takeuchi S Kodaira 1999 Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis Oncology 57 2 138 142 10461061 1:STN:280:DyaK1MzptFykug%3D%3D
52. YS Shieh YJ Hung CB Hsieh, et al. 2009 Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands Ann Surg Oncol 16 3 751 760 19116756
53. E Barbera-Guillem JK Nyhus CC Wolford, et al. 2002 Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process Cancer Res 62 23 7042 7049 12460925 1:CAS:528:DC%2BD38XpsVahtr8%3D
54. J Condeelis JW Pollard 2006 Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 124 2 263 266 16439202 1:CAS:528:DC%2BD28Xht1KktLo%3D
55. EY Lin JF Li L Gnatovskiy, et al. 2006 Macrophages regulate the angiogenic switch in a mouse model of breast cancer Cancer Res 66 23 11238 11246 17114237 1:CAS:528:DC%2BD28Xht1KnsL%2FI
56. EY Lin AV Nguyen RG Russell, et al. 2001 Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy J Exp Med 193 6 727 740 11257139 1:CAS:528:DC%2BD3MXitFKhsLo%3D
57. SM Zeisberger B Odermatt C Marty, et al. 2006 Clodronate-liposome- mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach Br J Cancer 95 3 272 281 16832418 1:CAS:528:DC%2BD28Xnsl2iu7o%3D
58. NR Miselis ZJ Wu N Van Rooijen, et al. 2008 Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma Mol Cancer Ther 7 4 788 799 18375821 1:CAS:528:DC%2BD1cXks1Gms7g%3D
59. JP Herbeuval E Lelievre C Lambert, et al. 2004 Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6 J Immunol 172 7 4630 4636 15034082 1:CAS:528:DC%2BD2cXitlOqur8%3D
60. G Galizia M Orditura C Romano, et al. 2002 Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery Clin Immunol 102 2 169 178 11846459 1:CAS:528:DC%2BD38XisFWmtLk%3D
61. ZV Popovic R Sandhoff TP Sijmonsma, et al. 2007 Sulfated glycosphingolipid as mediator of phagocytosis: SM4s enhances apoptotic cell clearance and modulates macrophage activity J Immunol 179 10 6770 6782 17982067 1:CAS:528:DC%2BD2sXht1CrsrbL
62. PA Adegboyega O Ololade J Saada, et al. 2004 Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas Clin Cancer Res 10 17 5870 5879 15355919 1:CAS:528:DC%2BD2cXntlyjtr8%3D
63. JW Pollard 2004 Tumour-educated macrophages promote tumour progression and metastasis Nat Rev Cancer 4 1 71 78 14708027 1:CAS:528: DC%2BD2cXos12qtA%3D%3D
64. D Sickert DE Aust S Langer, et al. 2005 Characterization of macrophage subpopulations in colon cancer using tissue microarrays Histopathology 46 5 515 521 15842633 1:STN:280:DC%2BD2M3gvVylsQ%3D%3D
65. B Burke A Giannoudis KP Corke, et al. 2003 Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy Am J Pathol 163 4 1233 1243 14507633 1:CAS:528:DC%2BD3sXotlegsb8%3D
66. Y Mizukami Y Kohgo DC Chung 2007 Hypoxia inducible factor-1 independent pathways in tumor angiogenesis Clin Cancer Res 13 19 5670 5674 17908955 1:CAS:528:DC%2BD2sXhtFSntLzL
67. T Etoh K Shibuta GF Barnard, et al. 2000 Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration Clin Cancer Res 6 9 3545 3551 10999742 1:CAS:528:DC%2BD3cXntFCisL8%3D
68. PK Baier S Eggstein G Wolff-Vorbeck, et al. 2005 Chemokines in human colorectal carcinoma Anticancer Res 25 5 3581 3584 16101183 1:CAS:528: DC%2BD2MXps1Kguro%3D
69. SJ Kim JS Kim J Papadopoulos, et al. 2009 Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis Am J Pathol 174 5 1972 1980 19349357 1:CAS:528:DC%2BD1MXlvVWms7c%3D
70. S Aharinejad D Abraham P Paulus, et al. 2002 Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice Cancer Res 62 18 5317 5324 12235002 1:CAS:528:DC%2BD38Xnt1ynsbg%3D
71. F Bataille C Rohrmeier R Bates, et al. 2008 Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease Inflamm Bowel Dis 14 11 1514 1527 18626977
72. RC Bates BM Pursell AM Mercurio 2007 Epithelial-mesenchymal transition and colorectal cancer: gaining insights into tumor progression using LIM 1863 cells Cells Tissues Organs 185 1-3 29 39 17587805
73. RC Bates AM Mercurio 2003 Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids Mol Biol Cell 14 5 1790 1800 12802055 1:CAS:528:DC%2BD3sXktFKiuro%3D
74. RC Bates MJ DeLeo III AM Mercurio 2004 The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis Exp Cell Res 299 2 315 324 15350531 1:CAS:528:DC%2BD2cXntlOhs7g%3D
75. G Liu W Ding X Liu, et al. 2006 c-Fos is required for TGFbeta1 production and the associated paracrine migratory effects of human colon carcinoma cells Mol Carcinog 45 8 582 593 16637060 1:CAS:528:DC%2BD28XotVSjtrk%3D
76. R Paduch M Kandefer-Szerszen 2009 Transforming growth factor-beta1 (TGF-beta1) and acetylcholine (ACh) alter nitric oxide (NO) and interleukin-1beta (IL-1beta) secretion in human colon adenocarcinoma cells In Vitro Cell Dev Biol Anim 45 9 543 550 19551451 1:CAS:528:DC%2BD1MXhtFCgtbrO
77. A Mantovani B Bottazzi F Colotta, et al. 1992 The origin and function of tumor-associated macrophages Immunol Today 13 7 265 270 1388654 1:CAS:528:DyaK38XlsVyltrY%3D
78. F Li Y Cao CM Townsend Jr, et al. 2005 TGF-beta signaling in colon cancer cells World J Surg 29 3 306 311 15711891
79. A Reinacher-Schick SE Baldus B Romdhana, et al. 2004 Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas J Pathol 202 4 412 420 15095268 1:CAS:528: DC%2BD2cXjsFegu74%3D
80. S Thuault EJ Tan H Peinado, et al. 2008 HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition J Biol Chem 283 48 33437 33446 18832382 1:CAS:528:DC%2BD1cXhsVSgt73P
81. S Thuault U Valcourt M Petersen, et al. 2006 Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition J Cell Biol 174 2 175 183 16831886 1:CAS:528:DC%2BD28XntFaqsbo%3D
82. OR Mook WM Frederiks CJ Van Noorden 2004 The role of gelatinases in colorectal cancer progression and metastasis Biochim Biophys Acta 1705 2 69 89 15588763 1:CAS:528:DC%2BD2cXhtVGgurvE
83. M Illemann N Bird A Majeed, et al. 2006 MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases Mol Cancer Res 4 5 293 302 16687484 1:CAS:528:DC%2BD28XktlymsLg%3D
84. E Gounaris CH Tung C Restaino, et al. 2008 Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth PLoS One 3 8 e2916 18698347
85. MM Mohamed BF Sloane 2006 Cysteine cathepsins: multifunctional enzymes in cancer Nat Rev Cancer 6 10 764 775 16990854 1:CAS:528:DC%2BD28XpvVCmu7Y%3D
86. V Gocheva JA Joyce 2007 Cysteine cathepsins and the cutting edge of cancer invasion Cell Cycle 6 1 60 64 17245112 1:CAS:528:DC%2BD2sXnvFygsbc%3D
87. SR Harvey SN Sait Y Xu, et al. 1999 Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization Am J Pathol 155 4 1115 1120 10514394 1:CAS:528:DyaK1MXntFWmtr0%3D
88. S Laufs J Schumacher H Allgayer 2006 Urokinase-receptor (u-PAR): an essential player in multiple games of cancer: a review on its role in tumor progression, invasion, metastasis, proliferation/dormancy, clinical outcome and minimal residual disease Cell Cycle 5 16 1760 1771 16931909 1:CAS:528: DC%2BD28Xht1Gnt7rJ
89. WJ Lubbe DS Zuzga Z Zhou, et al. 2009 Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9 Cancer Res 69 8 3529 3536 19336567 1:CAS:528:DC%2BD1MXksV2ht74%3D
90. MJ Sinnamon KJ Carter B Fingleton, et al. 2008 Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse Int J Exp Pathol 89 6 466 475 19134056
91. PK Baier G Wolff-Vorbeck S Eggstein, et al. 2005 Cytokine expression in colon carcinoma Anticancer Res 25 3B 2135 2139 16158955 1:CAS:528: DC%2BD2MXmtl2huro%3D
92. A Mantovani S Sozzani M Locati, et al. 2002 Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 11 549 555 12401408 1:CAS:528:DC%2BD38XotVKktrc%3D
93. S Sakaguchi 2005 Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self Nat Immunol 6 4 345 352 15785760 1:CAS:528:DC%2BD2MXisVyitLY%3D
94. MJ Smyth MW Teng J Swann, et al. 2006 CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer J Immunol 176 3 1582 1587 16424187 1:CAS:528:DC%2BD28XlsFynsw%3D%3D
95. Sinicrope FA, Rego RL, Ansell SM, et al (2009) A low intraepithelial effector (CD3(+))/Regulatory (FoxP3(+)) T-cell ratio predicts adverse outcome of human colon carcinoma. Gastroenterology. 137(4):1270-1279
96. DI Gabrilovich V Bronte SH Chen, et al. 2007 The terminology issue for myeloid-derived suppressor cells Cancer Res 67 1 425 17210725 1:CAS:528:DC%2BD2sXisFWitA%3D%3D author reply 426
97. S Nagaraj DI Gabrilovich 2008 Tumor escape mechanism governed by myeloid-derived suppressor cells Cancer Res 68 8 2561 2563 18413722 1:CAS:528:DC%2BD1cXks1Git7s%3D
98. S Mandruzzato S Solito E Falisi, et al. 2009 IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients J Immunol 182 10 6562 6568 19414811 1:CAS:528:DC%2BD1MXltlymt7Y%3D
99. AC Ochoa AH Zea C Hernandez, et al. 2007 Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma Clin Cancer Res 13 2 Pt 2 721s 726s 17255300 1:CAS:528:DC%2BD2sXoslSqsQ%3D%3D
100. B Almand JI Clark E Nikitina, et al. 2001 Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer J Immunol 166 1 678 689 11123353 1:CAS:528:DC%2BD3MXis1elsw%3D%3D
101. CM Diaz-Montero ML Salem MI Nishimura, et al. 2009 Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy Cancer Immunol Immunother 58 1 49 59 18446337 1:CAS:528:DC%2BD1cXht1yqs7bN
102. N Umemura M Saio T Suwa, et al. 2008 Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics J Leukoc Biol 83 5 1136 1144 18285406 1:CAS:528:DC%2BD1cXlsVWnsrc%3D
103. DI Gabrilovich S Nagaraj 2009 Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 9 3 162 174 19197294 1:CAS:528:DC%2BD1MXhsFeqsbw%3D
104. S Cascio R Ferla A D'Andrea, et al. 2009 Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells J Cell Physiol 221 1 189 194 19492417 1:CAS:528:DC%2BD1MXptlOntrg%3D
105. MK Donkor E Lahue TA Hoke, et al. 2009 Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells Int Immunopharmacol 9 7-8 937 948 19362167 1:CAS:528:DC%2BD1MXms1Ors7w%3D
106. S Nagaraj K Gupta V Pisarev, et al. 2007 Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer Nat Med 13 7 828 835 17603493 1:CAS:528:DC%2BD2sXnsFWmt7w%3D
107. B Huang PY Pan Q Li, et al. 2006 Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host Cancer Res 66 2 1123 1131 16424049 1:CAS:528:DC%2BD28XlsFOgug%3D%3D
108. L Yang LM DeBusk K Fukuda, et al. 2004 Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis Cancer Cell 6 4 409 421 15488763 1:CAS:528:DC%2BD2cXpsF2rtLo%3D
109. K Movahedi M Guilliams J Van den Bossche, et al. 2008 Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity Blood 111 8 4233 4244 18272812 1:CAS:528:DC%2BD1cXkvFeisb4%3D
110. P Sinha VK Clements AM Fulton, et al. 2007 Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells Cancer Res 67 9 4507 4513 17483367 1:CAS:528:DC%2BD2sXltVyrtrY%3D
111. Y Zhang Q Liu M Zhang, et al. 2009 Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2 J Immunol 182 6 3801 3808 19265159 1:CAS:528:DC%2BD1MXis12hsLY%3D
112. TG Kormelink A Abudukelimu FA Redegeld 2009 Mast cells as target in cancer therapy Curr Pharm Des 15 16 1868 1878
113. D Ribatti A Vacca B Nico, et al. 2001 The role of mast cells in tumour angiogenesis Br J Haematol 115 3 514 521 11736931 1:STN:280: DC%2BD3MnptFSrsQ%3D%3D
114. E Crivellato B Nico D Ribatti 2008 Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis Cancer Lett 269 1 1 6 18450371 1:CAS:528:DC%2BD1cXhtVagtrbE
115. ER Fisher SM Paik H Rockette, et al. 1989 Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01) Hum Pathol 20 2 159 163 2562788 1:STN:280:DyaL1M7itF2lsg%3D%3D
116. M Gulubova T Vlaykova 2009 Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer J Gastroenterol Hepatol 24 7 1265 1275 17645466
117. B Huang Z Lei GM Zhang, et al. 2008 SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment Blood 112 4 1269 1279 18524989 1:CAS:528:DC%2BD1cXpvVOkt7g%3D
118. A Grutzkau S Kruger-Krasagakes H Baumeister, et al. 1998 Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206 Mol Biol Cell 9 4 875 884 9529385 1:CAS:528: DyaK1cXisFSnt7s%3D
119. Z Qu JM Liebler MR Powers, et al. 1995 Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma Am J Pathol 147 3 564 573 7545872 1:CAS:528:DyaK2MXoslKjsL0%3D
120. XP Lin WX Liu J Li 2004 The study on expression of bFGF and quantity of mast cell in infant hemangiomas of grandulae parotid gland Shanghai Kou Qiang Yi Xue 13 3 167 15269849 172, 178
121. J Hallgren S Estrada U Karlson, et al. 2001 Heparin antagonists are potent inhibitors of mast cell tryptase Biochemistry 40 24 7342 7349 11401583 1:CAS:528:DC%2BD3MXjs1Ght7w%3D
122. G Pejler JE Sadler 1999 Mechanism by which heparin proteoglycan modulates mast cell chymase activity Biochemistry 38 37 12187 12195 10508424 1:CAS:528:DyaK1MXlt1ansrY%3D
123. PF Bowrey J King C Magarey, et al. 2000 Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect? Br J Cancer 82 1 167 170 10638985 1:CAS:528: DC%2BD3cXltFWktQ%3D%3D
124. AM Dvorak 2005 Mast cell-derived mediators of enhanced microvascular permeability, vascular permeability factor/vascular endothelial growth factor, histamine, and serotonin, cause leakage of macromolecules through a new endothelial cell permeability organelle, the vesiculo-vacuolar organelle Chem Immunol Allergy 85 185 204 15970658
125. S Nakae H Suto GJ Berry, et al. 2007 Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice Blood 109 9 3640 3648 17197430 1:CAS:528:DC%2BD2sXkvFCitr0%3D
126. M Kneilling R Mailhammer L Hultner, et al. 2009 Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammation Blood 114 8 1696 1706 19546478 1:CAS:528:DC%2BD1MXhtVyiurvI
127. T Nakayama L Yao G Tosato 2004 Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors J Clin Invest 114 9 1317 1325 15520864 1:CAS:528:DC%2BD2cXpsFCgtrk%3D
128. D Ribatti E Crivellato 2009 The controversial role of mast cells in tumor growth Int Rev Cell Mol Biol 275 89 131 19491054 1:CAS:528:DC%2BD1MXhtVSnsbbE
129. D Ribatti E Crivellato S Molica 2009 Mast cells and angiogenesis in haematological malignancies Leuk Res 33 7 876 879 19324412 1:CAS:528: DC%2BD1MXlsVGqurs%3D
130. LM Coussens WW Raymond G Bergers, et al. 1999 Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis Genes Dev 13 11 1382 1397 10364156 1:CAS:528:DyaK1MXjvVahs7Y%3D
131. E Gounaris SE Erdman C Restaino, et al. 2007 Mast cells are an essential hematopoietic component for polyp development Proc Natl Acad Sci U S A 104 50 19977 19982 18077429 1:CAS:528:DC%2BD1cXitFWjtQ%3D%3D
132. Y Kashiwase H Inamura J Morioka, et al. 2008 Quantitative analysis of mast cells in benign and malignant colonic lesions: immunohistochemical study on formalin-fixed, paraffin-embedded tissues Allergol Immunopathol (Madr) 36 5 271 276 1:STN:280:DC%2BD1M%2FjtFyqtg%3D%3D
133. M Taweevisit 2006 The association of stromal mast cell response and tumor cell differentiation in colorectal cancer J Med Assoc Thai 89 Suppl 3 S69 S73 17718271
134. M Yoshii A Jikuhara S Mori, et al. 2005 Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners J Pharmacol Sci 98 4 450 458 16093613 1:CAS:528:DC%2BD2MXps1Omtbg%3D
135. S Maltby K Khazaie KM McNagny 2009 Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation Biochim Biophys Acta 1796 1 19 26 19233249 1:CAS:528:DC%2BD1MXhtVenurvO
136. S Nakae H Suto M Iikura, et al. 2006 Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF J Immunol 176 4 2238 2248 16455980 1:CAS:528:DC%2BD28XpvV2mtQ%3D%3D
137. L Simson JI Ellyard LA Dent, et al. 2007 Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance J Immunol 178 7 4222 4229 17371978 1:CAS:528:DC%2BD2sXjt1Wlur4%3D
138. PH Hart SL Townley MA Grimbaldeston, et al. 2002 Mast cells, neuropeptides, histamine, and prostaglandins in UV-induced systemic immunosuppression Methods 28 1 79 89 12231191 1:CAS:528:DC%2BD38XmslOiu7w%3D
139. H Harizi M Juzan V Pitard, et al. 2002 Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions J Immunol 168 5 2255 2263 11859113 1:CAS:528:DC%2BD38XhvVegsrs%3D
140. MJ Sinnamon KJ Carter LP Sims, et al. 2008 A protective role of mast cells in intestinal tumorigenesis Carcinogenesis 29 4 880 886 18258601 1:CAS:528:DC%2BD1cXktlOhu7g%3D
141. D Noviana F Kono Y Nagakui, et al. 2001 Distribution and enzyme histochemical characterisation of mast cells in cats Histochem J 33 11-12 597 603 12197667 1:CAS:528:DC%2BD38Xltlemtb4%3D
142. H Shimizu Y Nagakui K Tsuchiya, et al. 2001 Demonstration of chymotryptic and tryptic activities in mast cells of rodents: comparison of 17 species of the family Muridae J Comp Pathol 125 1 76 79 11437520 1:STN:280: DC%2BD3MzosVOntw%3D%3D
143. T Kitamura K Kometani H Hashida, et al. 2007 SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion Nat Genet 39 4 467 475 17369830 1:CAS:528:DC%2BD2sXjsV2hs7w%3D
144. E Drew CS Huettner DG Tenen, et al. 2005 CD34 expression by mast cells: of mice and men Blood 106 5 1885 1887 16113233 1:CAS:528:DC%2BD2MXps1OgtLk%3D
145. E Drew H Merkens S Chelliah, et al. 2002 CD34 is a specific marker of mature murine mast cells Exp Hematol 30 10 1211 12384153 1:CAS:528: DC%2BD38XnvVOqsbw%3D
146. E Drew JS Merzaban W Seo, et al. 2005 CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution Immunity 22 1 43 57 15664158 1:CAS:528:DC%2BD2MXht1CgsLY%3D
147. A Tanaka Y Yamane H Matsuda 2001 Mast cell MMP-9 production enhanced by bacterial lipopolysaccharide J Vet Med Sci 63 7 811 813 11503911 1:CAS:528:DC%2BD3MXmtFelurw%3D
148. D Linnekin 1999 Early signaling pathways activated by c-Kit in hematopoietic cells Int J Biochem Cell Biol 31 10 1053 1074 10582339 1:CAS:528:DyaK1MXmsVWitrc%3D
149. SA Berger TW Mak CJ Paige 1994 Leukocyte common antigen (CD45) is required for immunoglobulin E-mediated degranulation of mast cells J Exp Med 180 2 471 476 8046327 1:CAS:528:DyaK2cXltVKnsLg%3D
150. R Kalluri M Zeisberg 2006 Fibroblasts in cancer Nat Rev Cancer 6 5 392 401 16572188 1:CAS:528:DC%2BD28XjslGitLw%3D
151. A Ostman M Augsten 2009 Cancer-associated fibroblasts and tumor growth-bystanders turning into key players Curr Opin Genet Dev 19 1 67 73 19211240
152. H Sugimoto TM Mundel MW Kieran, et al. 2006 Identification of fibroblast heterogeneity in the tumor microenvironment Cancer Biol Ther 5 12 1640 1646 17106243 1:CAS:528:DC%2BD2sXksVyru7c%3D
153. LR Henry HO Lee JS Lee, et al. 2007 Clinical implications of fibroblast activation protein in patients with colon cancer Clin Cancer Res 13 6 1736 1741 17363526 1:CAS:528:DC%2BD2sXivV2gt7o%3D
154. H Nakagawa S Liyanarachchi RV Davuluri, et al. 2004 Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles Oncogene 23 44 7366 7377 15326482 1:CAS:528:DC%2BD2cXnsleltb4%3D
155. L Mueller FA Goumas M Affeldt, et al. 2007 Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment Am J Pathol 171 5 1608 1618 17916596 1:CAS:528:DC%2BD2sXhtlKqsLnP
156. NC Direkze K Hodivala-Dilke R Jeffery, et al. 2004 Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts Cancer Res 64 23 8492 8495 15574751 1:CAS:528:DC%2BD2cXhtVCjs7%2FL
157. L Yang C Lin ZR Liu 2006 P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin Cell 127 1 139 155 17018282 1:CAS:528:DC%2BD28XhtFSitr%2FF
158. MS Joesting S Perrin B Elenbaas, et al. 2005 Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer Cancer Res 65 22 10423 10430 16288033 1:CAS:528:DC%2BD2MXht1Wgu77F
159. CQ Zhu SN Popova ER Brown, et al. 2007 Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells Proc Natl Acad Sci U S A 104 28 11754 11759 17600088 1:CAS:528:DC%2BD2sXotVaksbc%3D
160. K Taniwaki H Fukamachi K Komori, et al. 2007 Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in
161. A Orimo PB Gupta DC Sgroi, et al. 2005 Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 3 335 348 15882617 1:CAS:528: DC%2BD2MXktlSiu7w%3D
162. A Orimo RA Weinberg 2006 Stromal fibroblasts in cancer: a novel tumor-promoting cell type Cell Cycle 5 15 1597 1601 16880743 1:CAS:528:DC%2BD28Xht12ht73P
163. PA Konstantinopoulos GP Vandoros MV Karamouzis, et al. 2007 EGF-R is expressed and AP-1 and NF-kappaB are activated in stromal myofibroblasts surrounding colon adenocarcinomas paralleling expression of COX-2 and VEGF Cell Oncol 29 6 477 482 18032824 1:CAS:528:DC%2BD2sXhtlajtL%2FJ
164. GP Vandoros PA Konstantinopoulos G Sotiropoulou-Bonikou, et al. 2006 PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas J Cancer Res Clin Oncol 132 2 76 84 16215757 1:CAS:528:DC%2BD2MXht1Oqsb7I
165. R Fodde R Smits H Clevers 2001 APC, signal transduction and genetic instability in colorectal cancer Nat Rev Cancer 1 1 55 67 11900252 1:STN:280:DC%2BD387mvVOhtA%3D%3D
166. R Fodde T Brabletz 2007 Wnt/beta-catenin signaling in cancer stemness and malignant behavior Curr Opin Cell Biol 19 2 150 158 17306971 1:CAS:528:DC%2BD2sXjt1Slu7s%3D
167. NH Le P Franken R Fodde 2008 Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness Br J Cancer 98 12 1886 1893 18506144 1:CAS:528:DC%2BD1cXmvV2htbs%3D
168. AL Eisinger LD Nadauld DN Shelton, et al. 2006 The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid J Biol Chem 281 29 20474 20482 16699180 1:CAS:528:DC%2BD28XmvFeqtbk%3D
169. AL Eisinger SM Prescott DA Jones, et al. 2007 The role of cyclooxygenase-2 and prostaglandins in colon cancer Prostaglandins Other Lipid Mediat 82 1-4 147 154 17164142 1:CAS:528:DC%2BD28Xht12ktL%2FE
170. D Wang JR Mann RN DuBois 2004 WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth Cell Cycle 3 12 1512 1515 15539957 1:CAS:528:DC%2BD28XjtVersLY%3D
171. D Wang H Wang Q Shi, et al. 2004 Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta Cancer Cell 6 3 285 295 15380519 1:CAS:528:DC%2BD2cXot1KisL4%3D
172. Y Kitadai T Sasaki T Kuwai, et al. 2006 Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential Int J Cancer 119 11 2567 2574 16988946 1:CAS:528:DC%2BD28XhtFygtbfP
173. Y Kitadai T Sasaki T Kuwai, et al. 2006 Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma Am J Pathol 169 6 2054 2065 17148668 1:CAS:528:DC%2BD2sXhvV2gsg%3D%3D (Pubitemid 351181965)
174. Y Crawford I Kasman L Yu, et al. 2009 PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment Cancer Cell 15 1 21 34 19111878 1:CAS:528: DC%2BD1MXptVGqtQ%3D%3D
175. G Francia U Emmenegger RS Kerbel 2009 Tumor-associated fibroblasts as "Trojan Horse" mediators of resistance to anti-VEGF therapy Cancer Cell 15 1 3 5 19111874 1:CAS:528:DC%2BD1MXptVGqsQ%3D%3D
176. M De Palma MA Venneri R Galli, et al. 2005 Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors Cancer Cell 8 3 211 226 16169466
177. MA Venneri M De Palma M Ponzoni, et al. 2007 Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer Blood 109 12 5276 5285 17327411 1:CAS:528:DC%2BD2sXmslOrsL8%3D
178. C Murdoch S Tazzyman S Webster, et al. 2007 Expression of Tie-2 by human monocytes and their responses to angiopoietin-2 J Immunol 178 11 7405 7411 17513791 1:CAS:528:DC%2BD2sXlsVOksrg%3D
179. CE Lewis M De Palma L Naldini 2007 Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2 Cancer Res 67 18 8429 8432 17875679 1:CAS:528:DC%2BD2sXhtVCit7%2FE (Pubitemid 47437413)
180. LM Ellis S Ahmad F Fan, et al. 2002 Angiopoietins and their role in colon cancer angiogenesis Oncology (Williston Park) 16 4 Suppl 3 31 35
181. M De Palma L Naldini 2009 Tie2-expressing monocytes (TEMs): novel targets and vehicles of anticancer therapy? Biochim Biophys Acta 1796 1 5 10 19362584
182. S Sarraf-Yazdi J Mi BJ Moeller, et al. 2008 Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer J Surg Res 146 1 16 23 17950331 1:CAS:528:DC%2BD1cXksVaiu7c%3D
183. M Eck B Schmausser K Scheller, et al. 2003 Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma Clin Exp Immunol 134 3 508 515 14632759 1:CAS:528:DC%2BD2cXis1Kluw%3D%3D
184. L Roncucci E Mora F Mariani, et al. 2008 Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk Cancer Epidemiol Biomarkers Prev 17 9 2291 2297 18768495 1:CAS:528: DC%2BD1cXhtVKmtLjP
185. A Roessner D Kuester P Malfertheiner, et al. 2008 Oxidative stress in ulcerative colitis-associated carcinogenesis Pathol Res Pract 204 7 511 524 18571874 1:STN:280:DC%2BD1cvks1KnsQ%3D%3D
186. K Xie 2001 Interleukin-8 and human cancer biology Cytokine Growth Factor Rev 12 4 375 391 11544106 1:CAS:528:DC%2BD3MXmsFChtLg%3D
187. S Tazzyman CE Lewis C Murdoch 2009 Neutrophils: key mediators of tumour angiogenesis Int J Exp Pathol 90 3 222 231 19563607 1:CAS:528: DC%2BD1MXotV2ju7g%3D
188. MM Queen RE Ryan RG Holzer, et al. 2005 Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression Cancer Res 65 19 8896 8904 16204061 1:CAS:528:DC%2BD2MXhtVKiu73P
189. LJ Hawinkels K Zuidwijk HW Verspaget, et al. 2008 VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis Eur J Cancer 44 13 1904 1913 18691882 1:CAS:528:DC%2BD1cXhtVamt7vN
190. M McCourt JH Wang S Sookhai, et al. 1999 Proinflammatory mediators stimulate neutrophil-directed angiogenesis Arch Surg 134 12 1325 1331 10593330 1:CAS:528:DC%2BD3cXivFKmtA%3D%3D discussion 1331-1322
191. MA Cassatella 1999 Neutrophil-derived proteins: selling cytokines by the pound Adv Immunol 73 369 509 10399011 1:CAS:528:DC%2BD3cXht1alsrk%3D
192. H Nozawa C Chiu D Hanahan 2006 Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis Proc Natl Acad Sci U S A 103 33 12493 12498 16891410 1:CAS:528:DC%2BD28Xos1OjurY%3D
193. AM Knaapen RP Schins D Polat, et al. 2002 Mechanisms of neutrophil-induced DNA damage in respiratory tract epithelial cells Mol Cell Biochem 234-235 1-2 143 151 12162427
194. IT Vermeer LY Henderson EJ Moonen, et al. 2004 Neutrophil-mediated formation of carcinogenic N-nitroso compounds in an in vitro model for intestinal inflammation Toxicol Lett 154 3 175 182 15501609 1:CAS:528: DC%2BD2cXovVKrtrY%3D
195. M Ten Kate AG Aalbers W Sluiter, et al. 2007 Polymorphonuclear leukocytes increase the adhesion of circulating tumor cells to microvascular endothelium Anticancer Res 27 1A 17 22 17352210
196. MP van den Tol S ten Raa WM van Grevenstein, et al. 2007 The post-surgical inflammatory response provokes enhanced tumour recurrence: a crucial role for neutrophils Dig Surg 24 5 388 394 17785985
197. E Di Carlo G Forni P Lollini, et al. 2001 The intriguing role of polymorphonuclear neutrophils in antitumor reactions Blood 97 2 339 345 11154206
198. E di Carlo M Iezzi T Pannellini, et al. 2001 Neutrophils in anti-cancer immunological strategies: old players in new games J Hematother Stem Cell Res 10 6 739 748 11798500
199. P Scapini JA Lapinet-Vera S Gasperini, et al. 2000 The neutrophil as a cellular source of chemokines Immunol Rev 177 195 203 11138776 1:CAS:528:DC%2BD3cXptVent74%3D
200. KP van Gisbergen TB Geijtenbeek Y van Kooyk 2005 Close encounters of neutrophils and DCs Trends Immunol 26 12 626 631 16182604
201. ZG Fridlender J Sun S Kim, et al. 2009 Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN Cancer Cell 16 3 183 194 19732719 1:CAS:528:DC%2BD1MXhsVChs7vN
202. F Pages A Berger M Camus, et al. 2005 Effector memory T cells, early metastasis, and survival in colorectal cancer N Engl J Med 353 25 2654 2666 16371631 1:CAS:528:DC%2BD2MXhtlarsrrE
203. M Morris C Platell B Iacopetta 2008 Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy Clin Cancer Res 14 5 1413 1417 18316563 1:CAS:528: DC%2BD1cXislSrsL8%3D
204. J Galon A Costes F Sanchez-Cabo, et al. 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 5795 1960 1964 17008531 1:CAS:528:DC%2BD28XhtVSnsrnK
205. M Waldner CC Schimanski MF Neurath 2006 Colon cancer and the immune system: the role of tumor invading T cells World J Gastroenterol 12 45 7233 7238 17143936 1:CAS:528:DC%2BD2sXmsVWlsw%3D%3D
206. E Gounaris NR Blatner K Dennis, et al. 2009 T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis Cancer Res 69 13 5490 5497 19570783 1:CAS:528:DC%2BD1MXnvFajs7w%3D
207. MP Colombo S Piconese 2009 Polyps wrap mast cells and Treg within tumorigenic tentacles Cancer Res 69 14 5619 5622 19567669 1:CAS:528: DC%2BD1MXosV2msr0%3D
208. S Yaqub K Henjum M Mahic, et al. 2008 Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner Cancer Immunol Immunother 57 6 813 821 17962941 1:CAS:528:DC%2BD1cXjvFKmtbw%3D
209. C Lonnroth M Andersson A Arvidsson, et al. 2008 Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer Cancer Immun 8 5 18307280
210. S Roux L Apetoh F Chalmin, et al. 2008 CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer J Clin Invest 118 11 3751 3761 18830416 1:CAS:528:DC%2BD1cXhtlGltLjK
211. S Shah AA Divekar SP Hilchey, et al. 2005 Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells Int J Cancer 117 4 574 586 15912532 1:CAS:528: DC%2BD2MXhtFKjs7rE
212. LL Lanier 2003 Natural killer cell receptor signaling Curr Opin Immunol 15 3 308 314 12787756 1:CAS:528:DC%2BD3sXkt1Knt70%3D
213. K Moriwaki K Noda Y Furukawa, et al. 2009 Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling Gastroenterology 137 1 188 198 19361506 1:CAS:528:DC%2BD1MXovFOgt70%3D 198 e181-182
214. TL Whiteside NL Vujanovic RB Herberman 1998 Natural killer cells and tumor therapy Curr Top Microbiol Immunol 230 221 244 9586358 1:CAS:528:DyaK1cXjt1ymt7c%3D
215. ES Doubrovina MM Doubrovin E Vider, et al. 2003 Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma J Immunol 171 12 6891 6899 14662896 1:CAS:528:DC%2BD3sXpsV2rur0%3D
216. AE Ryan F Shanahan J O'Connell, et al. 2006 Fas ligand promotes tumor immune evasion of colon cancer in vivo Cell Cycle 5 3 246 249 16418579 1:CAS:528:DC%2BD28XjvFOmt7k%3D
217. G O'Callaghan J Kelly F Shanahan, et al. 2008 Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells Br J Cancer 99 3 502 512 18648368
218. J Banchereau RM Steinman 1998 Dendritic cells and the control of immunity Nature 392 6673 245 252 9521319 1:CAS:528:DyaK1cXitFWrsr8%3D
219. BA Pockaj GD Basu LB Pathangey, et al. 2004 Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer Ann Surg Oncol 11 3 328 339 14993030
220. D Gabrilovich T Ishida T Oyama, et al. 1998 Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo Blood 92 11 4150 4166 9834220 1:CAS:528:DyaK1cXnslylsLw%3D
221. TJ Curiel P Cheng P Mottram, et al. 2004 Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer Cancer Res 64 16 5535 5538 15313886 1:CAS:528:DC%2BD2cXmslaltb8%3D
222. Wu YG, Wu GZ, Wang L, et al (2009) Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo. Med Oncol. PMID: 19669608
223. HM Verheul HM Pinedo 1998 Tumor growth: a putative role for platelets? Oncologist 3 2 II 10388096
224. GF Nash LF Turner MF Scully, et al. 2002 Platelets and cancer Lancet Oncol 3 7 425 430 12142172 1:CAS:528:DC%2BD38Xls1Wisr0%3D
225. S Karpatkin 2003 Role of thrombin in tumor angiogenesis, implantation, and metastasis Pathophysiol Haemost Thromb 33 Suppl 1 54 55 12955005
226. A Falanga FR Rickles 1999 Pathophysiology of the thrombophilic state in the cancer patient Semin Thromb Hemost 25 2 173 182 10357085 1:STN:280:DyaK1M3otl2ktQ%3D%3D
227. GF Nash DC Walsh AK Kakkar 2001 The role of the coagulation system in tumour angiogenesis Lancet Oncol 2 10 608 613 11902551 1:CAS:528: DC%2BD3MXot1Ggsbo%3D
228. K Stellos B Bigalke H Langer, et al. 2009 Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells Eur Heart J 30 5 584 593 19109356 1:CAS:528:DC%2BD1MXis1ChsLY%3D
229. HG Kopp T Placke HR Salih 2009 Platelet-derived transforming growth factor-{beta} down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity Cancer Res 69 19 7775 7783 19738039 1:CAS:528: DC%2BD1MXht1Skt7nP
230. OJ McCarty SA Mousa PF Bray, et al. 2000 Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions Blood 96 5 1789 1797 10961878 1:CAS:528:DC%2BD3cXmt1Omtbg%3D
231. MM Burdick K Konstantopoulos 2004 Platelet-induced enhancement of LS174T colon carcinoma and THP-1 monocytoid cell adhesion to vascular endothelium under flow Am J Physiol Cell Physiol 287 2 C539 C547 15084476 1:CAS:528: DC%2BD2cXmvVKntrg%3D
232. L Ricci-Vitiani E Fabrizi E Palio, et al. 2009 Colon cancer stem cells J Mol Med 87 11 1097 1104 19727638
233. EH Lin M Hassan Y Li, et al. 2007 Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence Cancer 110 3 534 542 17594720 1:CAS:528:DC%2BD2sXpt1yqu7w%3D
234. KC Kemp J Hows C Donaldson 2005 Bone marrow-derived mesenchymal stem cells Leuk Lymphoma 46 11 1531 1544 16236607
235. MF Pittenger AM Mackay SC Beck, et al. 1999 Multilineage potential of adult human mesenchymal stem cells Science 284 5411 143 147 10102814 1:CAS:528:DyaK1MXitlCnu7o%3D
236. DJ Prockop 1997 Marrow stromal cells as stem cells for nonhematopoietic tissues Science 276 5309 71 74 9082988 1:CAS:528:DyaK2sXitlyqt7g%3D
237. B Hall M Andreeff F Marini 2007 The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles Handb Exp Pharmacol 180 263 283 17554513 1:CAS:528:DC%2BD2sXpsleis7g%3D
238. AE Karnoub AB Dash AP Vo, et al. 2007 Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 7162 557 563 17914389 1:CAS:528:DC%2BD2sXhtFagt7fI
239. AJ Nauta AB Kruisselbrink E Lurvink, et al. 2006 Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells J Immunol 177 4 2080 2087 16887966 1:CAS:528: DC%2BD28Xns1Kht7o%3D
240. AJ Nauta WE Fibbe 2007 Immunomodulatory properties of mesenchymal stromal cells Blood 110 10 3499 3506 17664353 1:CAS:528:DC%2BD2sXhtlarurzE
241. L Sanz P Santos-Valle V Alonso-Camino, et al. 2008 Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels Microvasc Res 75 3 308 314 18252255
242. H Ning F Yang M Jiang, et al. 2008 The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study Leukemia 22 3 593 599 18185520 1:STN:280:DC%2BD1c7nsVOktw%3D%3D
243. RS Kerbel 2008 Tumor angiogenesis N Engl J Med 358 19 2039 2049 18463380 1:CAS:528:DC%2BD1cXlsFyrtro%3D
244. HJ Choi MS Hyun GJ Jung, et al. 1998 Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence Oncology 55 6 575 581 9778626 1:STN:280:DyaK1cvltlGnsw%3D%3D
245. D Liao RS Johnson 2007 Hypoxia: a key regulator of angiogenesis in cancer Cancer Metastasis Rev 26 2 281 290 17603752 1:CAS:528:DC%2BD2sXotFWrtLw%3D
246. R Fukuda B Kelly GL Semenza 2003 Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1 Cancer Res 63 9 2330 2334 12727858 1:CAS:528:DC%2BD3sXjtlGmtLc%3D
247. F Finetti S Donnini A Giachetti, et al. 2009 Prostaglandin E2 primes the angiogenic switch via a synergic interaction with the endothelial fibroblast growth factor-2 pathway Circ Res 105 7 657 666 19713533 1:CAS:528: DC%2BD1MXhtFelsr3P
248. J Gao A Knutsen G Arbman, et al. 2009 Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer Dig Liver Dis 41 2 116 122 19038587 1:STN:280:DC%2BD1M%2Fmt1GgsA%3D%3D
249. S Onogawa Y Kitadai S Tanaka, et al. 2004 Regulation of vascular endothelial growth factor (VEGF)-C and VEGF-D expression by the organ microenvironment in human colon carcinoma Eur J Cancer 40 10 1604 1609 15196547 1:CAS:528:DC%2BD2cXkvVClsrs%3D
250. T Tammela TV Petrova K Alitalo 2005 Molecular lymphangiogenesis: new players Trends Cell Biol 15 8 434 441 16005628 1:CAS:528:DC%2BD2MXns1Witb8%3D
251. T Tammela A Saaristo M Lohela, et al. 2005 Angiopoietin-1 promotes lymphatic sprouting and hyperplasia Blood 105 12 4642 4648 15746084 1:CAS:528:DC%2BD2MXlsVWjtbc%3D
252. S Kazama T Watanabe T Kanazawa, et al. 2007 Vascular endothelial growth factor-C (VEGF-C) is a more specific risk factor for lymph node metastasis than VEGF-D in submucosal colorectal cancer Hepatogastroenterology 54 73 71 76 17419234
253. R Timpl M Dziadek 1986 Structure, development, and molecular pathology of basement membranes Int Rev Exp Pathol 29 1 112 3536789 1:CAS:528: DyaL2sXmsFSktg%3D%3D
254. C Hagios A Lochter MJ Bissell 1998 Tissue architecture: the ultimate regulator of epithelial function? Philos Trans R Soc Lond B Biol Sci 353 1370 857 870 9684283 1:CAS:528:DyaK1cXkslSnt7k%3D
255. I Rabinovitz AM Mercurio 1997 The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures J Cell Biol 139 7 1873 1884 9412479 1:CAS:528:DyaK1cXht12ktg%3D%3D
256. M Zapatka D Zboralski Y Radacz, et al. 2007 Basement membrane component laminin-5 is a target of the tumor suppressor Smad4 Oncogene 26 10 1417 1427 16953227 1:CAS:528:DC%2BD2sXit12rs7o%3D
257. D Tsuruta H Kobayashi H Imanishi, et al. 2008 Laminin-332-integrin interaction: a target for cancer therapy? Curr Med Chem 15 20 1968 1975 18691052 1:CAS:528:DC%2BD1cXhtVSrs7bK
258. SC Kirkland 2009 Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells Br J Cancer 101 2 320 326 19568234 1:CAS:528:DC%2BD1MXoslOlsr8%3D
259. J Ding D Li X Wang, et al. 2008 Fibronectin promotes invasiveness and focal adhesion kinase tyrosine phosphorylation of human colon cancer cell Hepatogastroenterology 55 88 2072 2076 19260479 1:CAS:528:DC%2BD1MXjs1Gqurk%3D
260. Y Hashimoto M Skacel JC Adams 2008 Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: an immunohistochemical study of clinically annotated tumors BMC Cancer 8 185 18590537
261. AD Theocharis 2002 Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin Biochim Biophys Acta 1588 2 165 172 12385781 1:CAS:528:DC%2BD38XnvVOktr4%3D
262. BP Toole 2004 Hyaluronan: from extracellular glue to pericellular cue Nat Rev Cancer 4 7 528 539 15229478 1:CAS:528:DC%2BD2cXlt1OktrY%3D
263. BP Toole TN Wight MI Tammi 2002 Hyaluronan-cell interactions in cancer and vascular disease J Biol Chem 277 7 4593 4596 11717318 1:CAS:528: DC%2BD38XhsFeqsbs%3D
264. HR Kim MA Wheeler CM Wilson, et al. 2004 Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44 Cancer Res 64 13 4569 4576 15231668 1:CAS:528:DC%2BD2cXltlOrsb0%3D
265. C Laurich MA Wheeler J Iida, et al. 2004 Hyaluronan mediates adhesion of metastatic colon carcinoma cells J Surg Res 122 1 70 74 15522317 1:CAS:528:DC%2BD2cXpt1Squ7o%3D
266. KM Dunn PK Lee CM Wilson, et al. 2009 Inhibition of hyaluronan synthases decreases matrix metalloproteinase-7 (MMP-7) expression and activity Surgery 145 3 322 329 19231585
267. S Misra BP Toole S Ghatak 2006 Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells J Biol Chem 281 46 34936 34941 16959784 1:CAS:528:DC%2BD28XhtF2gtbnM
268. S Ghatak S Misra BP Toole 2005 Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells J Biol Chem 280 10 8875 8883 15632176 1:CAS:528:DC%2BD2MXitVCisbg%3D
269. S Misra LM Obeid YA Hannun, et al. 2008 Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells J Biol Chem 283 21 14335 14344 18326857 1:CAS:528:DC%2BD1cXlvFyjsrs%3D
270. K Yazawa NH Tsuno J Kitayama, et al. 2005 Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of beta1 integrin Cancer Sci 96 2 93 99 15723653 1:CAS:528:DC%2BD2MXislOhs7o%3D
271. J Heino J Kapyla 2009 Cellular receptors of extracellular matrix molecules Curr Pharm Des 15 12 1309 1317 19355970 1:CAS:528:DC%2BD1MXmtValtr8%3D
272. OJ Broom R Massoumi A Sjolander 2006 Alpha2beta1 integrin signalling enhances cyclooxygenase-2 expression in intestinal epithelial cells J Cell Physiol 209 3 950 958 16972245 1:CAS:528:DC%2BD28XhtFOktLjF
273. CA Murillo PG Rychahou BM Evers 2004 Inhibition of alpha5 integrin decreases PI3K activation and cell adhesion of human colon cancers Surgery 136 2 143 149 15300173
274. LC van Kempen KE de Visser LM Coussens 2006 Inflammation, proteases and cancer Eur J Cancer 42 6 728 734 16524717
275. S Zucker J Vacirca 2004 Role of matrix metalloproteinases (MMPs) in colorectal cancer Cancer Metastasis Rev 23 1-2 101 117 15000152 1:CAS:528:DC%2BD3sXnsFansrY%3D
276. D Toda T Ota K Tsukuda, et al. 2006 Gefitinib decreases the synthesis of matrix metalloproteinase and the adhesion to extracellular matrix proteins of colon cancer cells Anticancer Res 26 1A 129 134 16475688 1:CAS:528: DC%2BD28Xhs1ahtr0%3D
277. ML Davidsen SO Wurtz MU Romer, et al. 2006 TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis Br J Cancer 95 8 1114 1120 17047657 1:CAS:528:DC%2BD28XhtVyitbbJ
278. NM Sorensen P Bystrom IJ Christensen, et al. 2007 TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid Clin Cancer Res 13 14 4117 4122 17634538
279. LM Packer SJ Williams S Callaghan, et al. 2004 Expression of the cell surface mucin gene family in adenocarcinomas Int J Oncol 25 4 1119 1126 15375564 1:CAS:528:DC%2BD2cXovFWkt74%3D
280. SE Baldus SP Monig S Huxel, et al. 2004 MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis Clin Cancer Res 10 8 2790 2796 15102686 1:CAS:528:DC%2BD2cXjt1Cltbs%3D
281. J Huang MI Che YT Huang, et al. 2009 Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells Carcinogenesis 30 8 1452 1458 19520792 1:CAS:528:DC%2BD1MXpsVaktLw%3D
282. PY Wai PC Kuo 2004 The role of osteopontin in tumor metastasis J Surg Res 121 2 228 241 15501463 1:CAS:528:DC%2BD2cXovVyru7c%3D
283. MK El-Tanani 2008 Role of osteopontin in cellular signaling and metastatic phenotype Front Biosci 13 4276 4284 18508510 1:CAS:528: DC%2BD1cXnsVOjsr0%3D
284. PY Wai Z Mi H Guo, et al. 2005 Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis Carcinogenesis 26 4 741 751 15661802 1:CAS:528:DC%2BD2MXis1yjtrw%3D
285. RB Irby SM McCarthy TJ Yeatman 2004 Osteopontin regulates multiple functions contributing to human colon cancer development and progression Clin Exp Metastasis 21 6 515 523 15679049 1:CAS:528:DC%2BD2MXhtlKrtr4%3D
286. R Zagani N Hamzaoui W Cacheux, et al. 2009 Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4a2-new therapeutic targets for colorectal cancers Gastroenterology 137 4 1358 1366 19549529 1:CAS:528:DC%2BD1MXht12gtrzM
287. Iacovazzi PA, Notarnicola M, Caruso MG, et al (2009) Serum levels of galectin-3 and its ligand 90 k/mac-2 bp in colorectal cancer patients. Immunopharmacol Immunotoxicol. PMID: 19686089
288. S Song N Mazurek C Liu, et al. 2009 Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity Cancer Res 69 4 1343 1349 19190323 1:CAS:528:DC%2BD1MXhslynsrg%3D
289. A Nobumoto K Nagahara S Oomizu, et al. 2008 Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices Glycobiology 18 9 735 744 18579572 1:CAS:528:DC%2BD1cXhtF2gsLzI
290. Y Kikuchi TG Kashima T Nishiyama, et al. 2008 Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon J Histochem Cytochem 56 8 753 764 18443362 1:CAS:528:DC%2BD1cXos1Cjtbc%3D
291. C Ma Y Rong DR Radiloff, et al. 2008 Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation Genes Dev 22 3 308 321 18245446